Compare 10X Genomics Inc (TXG) vs Materials Select Sector SPDR Fund (XLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Materials Select Sector SPDR Fund — how do they compare? 10X Genomics Inc trades at $84.15 (market cap $10.07B), while Materials Select Sector SPDR Fund trades at $49.4 (market cap $7.73B). The key difference: 10X Genomics Inc is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Materials Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold 10X Genomics Inc for 92 Days and Materials Select Sector SPDR Fund for 70 Days on average.
| TXG | XLB | |
|---|---|---|
Market Cap | $10.07B | $7.73B |
Volume | 5,657,286 | 13,681,146 |
Sector | Health | — |
52-Week High | $97.74 | $53.67 |
52-Week Low | $11.48 | $42.23 |
Typical Hold Time | 92 Days | 70 Days |
Enterprise Value | $9.59B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
XLB trades at $49.49, up 1.04% with a bearish technical signal from moving averages. The materials ETF shows neutral oscillators but faces selling pressure with ADX indicators signaling strong trends. Recent news highlights sector concentration risks with chemicals comprising 49% of assets, while infrastructure and manufacturing trends provide support. The ETF remains below its 200-day moving average of $50.93, indicating technical weakness.
Outlook remains cautious as materials sector faces cyclical headwinds with limited upside after recent rebound. Investment opportunity exists in AI-resistant businesses and infrastructure exposure, but risks include heavy concentration in chemicals and moderate overvaluation in construction materials. Wall Street sentiment appears mixed with some analysts viewing current levels as fully valued.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Materials Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →
